Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Chantibody Therapeutics Logo
Chantibody Therapeutics CB Rank
450721
Heat Score
58
Chantibody Therapeutics is a biotechnology company that works in developing therapeutics for life-threatening diseases such as cancer.
Founded
obfuscation
Private Mountain View, California, United States11-50 chantibody.com
Biotechnology
Medical
Therapeutics
Overview

Chantibody Therapeutics
Heat Score
58

Growth Score
pts
in past quarter
Heat Score 58
-23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Chantibody Therapeutics

CB Rank
450721
Chantibody Therapeutics is a biotechnology company that works in developing therapeutics for life-threatening diseases such as cancer.
Founded
obfuscation
Private Mountain View, California, United States11-50 chantibody.com
Biotechnology
Medical
Therapeutics

Details

Legal Name Chantibody Therapeutics Inc.
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Chantibody VHH Discovery Platform
A platform for discovering VHH antibodies to support the development of multi-modality therapeutics.
MSLN and MUC1 Dual-Targeting CAR-T Therapy
A CAR-T therapy targeting MSLN and MUC1 with conditional activation to improve tumor specificity and clinical safety.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 1
News
Technology
View Tech Report

Monthly Web Visits

93
-60.76%
 in past month

IT Spend

$48.3KThis year, Chantibody Therapeutics is projected to spend $48.3K on IT, according to Aberdeen.

Active Website Tech Count

3Chantibody Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 100m.
Sub-Organizations
Frequently Asked Questions

Where is Chantibody Therapeutics's headquarters? Chantibody Therapeutics is located in Mountain View, California, United States.Who are Chantibody Therapeutics's competitors? Alternatives and possible competitors to Chantibody Therapeutics may include Erasca, Compass Therapeutics, and  Genmab.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(53d292a 1)
|